Cargando…

Trends and Outcomes in Lung Transplantation in Patients with and without Idiopathic Pulmonary Fibrosis in Spain during the Period 2016–2020

(1) Background: This paper aims to assess temporal trends (2016–2020) in incidence, patient’s characteristics, complications, length of hospital stay (LOHS) and in-hospital mortality (IHM) among patients with and without idiopathic pulmonary fibrosis (IPF) undergoing lung transplantation (LTx). We a...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Muñiz Ballesteros, Belén, Lopez-de-Andres, Ana, Jimenez-Garcia, Rodrigo, Zamorano-Leon, Jose J., Carabantes-Alarcon, David, Cuadrado-Corrales, Natividad, Del-Barrio, Jose L., Perez-Farinos, Napoleon, De Miguel-Díez, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252271/
https://www.ncbi.nlm.nih.gov/pubmed/37297674
http://dx.doi.org/10.3390/healthcare11111534
_version_ 1785056130053963776
author López-Muñiz Ballesteros, Belén
Lopez-de-Andres, Ana
Jimenez-Garcia, Rodrigo
Zamorano-Leon, Jose J.
Carabantes-Alarcon, David
Cuadrado-Corrales, Natividad
Del-Barrio, Jose L.
Perez-Farinos, Napoleon
De Miguel-Díez, Javier
author_facet López-Muñiz Ballesteros, Belén
Lopez-de-Andres, Ana
Jimenez-Garcia, Rodrigo
Zamorano-Leon, Jose J.
Carabantes-Alarcon, David
Cuadrado-Corrales, Natividad
Del-Barrio, Jose L.
Perez-Farinos, Napoleon
De Miguel-Díez, Javier
author_sort López-Muñiz Ballesteros, Belén
collection PubMed
description (1) Background: This paper aims to assess temporal trends (2016–2020) in incidence, patient’s characteristics, complications, length of hospital stay (LOHS) and in-hospital mortality (IHM) among patients with and without idiopathic pulmonary fibrosis (IPF) undergoing lung transplantation (LTx). We also analyse the effect of the COVID-19 pandemic on LTx in these populations. (2) Methods: A retrospective, population-based observational study was conducted using the Spanish National Hospital Discharge Database. Multivariable adjustment was conducted with logistic regression to analyse the IHM. (3) Results: We identified 1777 admissions for LTx during the study period, of which 573 (32.2%) were performed in patients with IPF. The number of hospital admissions for LTx rose from 2016 to 2020, both in patients with and without IPF, but a marked reduction was observed from year 2019 to year 2020. Over time, the proportion of single LTx decreased and bilateral LTx increased significantly in both groups. The incidence of LTx complications increased significantly over time along with the increase in the incidence of IPF. No significant differences in the incidence of complications or in the IHM between patients with and without IPF were found. Suffering any complication of the LTx and pulmonary hypertension were conditions positively associated with IHM in patients with and without IPF. The IHM remained stable from 2016 to 2020 in both study populations and was not affected by the COVID pandemic. (4) Conclusions: Patients with IPF account for almost a third of all lung transplants. The number of LTx increased over time in patients with and without IPF, but a marked reduction was observed from 2019 to 2020. Although the proportion of LTx complications increased significantly over time in both groups, the IHM did not change. IPF was not associated with increased complications or IHM after LTx.
format Online
Article
Text
id pubmed-10252271
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102522712023-06-10 Trends and Outcomes in Lung Transplantation in Patients with and without Idiopathic Pulmonary Fibrosis in Spain during the Period 2016–2020 López-Muñiz Ballesteros, Belén Lopez-de-Andres, Ana Jimenez-Garcia, Rodrigo Zamorano-Leon, Jose J. Carabantes-Alarcon, David Cuadrado-Corrales, Natividad Del-Barrio, Jose L. Perez-Farinos, Napoleon De Miguel-Díez, Javier Healthcare (Basel) Article (1) Background: This paper aims to assess temporal trends (2016–2020) in incidence, patient’s characteristics, complications, length of hospital stay (LOHS) and in-hospital mortality (IHM) among patients with and without idiopathic pulmonary fibrosis (IPF) undergoing lung transplantation (LTx). We also analyse the effect of the COVID-19 pandemic on LTx in these populations. (2) Methods: A retrospective, population-based observational study was conducted using the Spanish National Hospital Discharge Database. Multivariable adjustment was conducted with logistic regression to analyse the IHM. (3) Results: We identified 1777 admissions for LTx during the study period, of which 573 (32.2%) were performed in patients with IPF. The number of hospital admissions for LTx rose from 2016 to 2020, both in patients with and without IPF, but a marked reduction was observed from year 2019 to year 2020. Over time, the proportion of single LTx decreased and bilateral LTx increased significantly in both groups. The incidence of LTx complications increased significantly over time along with the increase in the incidence of IPF. No significant differences in the incidence of complications or in the IHM between patients with and without IPF were found. Suffering any complication of the LTx and pulmonary hypertension were conditions positively associated with IHM in patients with and without IPF. The IHM remained stable from 2016 to 2020 in both study populations and was not affected by the COVID pandemic. (4) Conclusions: Patients with IPF account for almost a third of all lung transplants. The number of LTx increased over time in patients with and without IPF, but a marked reduction was observed from 2019 to 2020. Although the proportion of LTx complications increased significantly over time in both groups, the IHM did not change. IPF was not associated with increased complications or IHM after LTx. MDPI 2023-05-24 /pmc/articles/PMC10252271/ /pubmed/37297674 http://dx.doi.org/10.3390/healthcare11111534 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
López-Muñiz Ballesteros, Belén
Lopez-de-Andres, Ana
Jimenez-Garcia, Rodrigo
Zamorano-Leon, Jose J.
Carabantes-Alarcon, David
Cuadrado-Corrales, Natividad
Del-Barrio, Jose L.
Perez-Farinos, Napoleon
De Miguel-Díez, Javier
Trends and Outcomes in Lung Transplantation in Patients with and without Idiopathic Pulmonary Fibrosis in Spain during the Period 2016–2020
title Trends and Outcomes in Lung Transplantation in Patients with and without Idiopathic Pulmonary Fibrosis in Spain during the Period 2016–2020
title_full Trends and Outcomes in Lung Transplantation in Patients with and without Idiopathic Pulmonary Fibrosis in Spain during the Period 2016–2020
title_fullStr Trends and Outcomes in Lung Transplantation in Patients with and without Idiopathic Pulmonary Fibrosis in Spain during the Period 2016–2020
title_full_unstemmed Trends and Outcomes in Lung Transplantation in Patients with and without Idiopathic Pulmonary Fibrosis in Spain during the Period 2016–2020
title_short Trends and Outcomes in Lung Transplantation in Patients with and without Idiopathic Pulmonary Fibrosis in Spain during the Period 2016–2020
title_sort trends and outcomes in lung transplantation in patients with and without idiopathic pulmonary fibrosis in spain during the period 2016–2020
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252271/
https://www.ncbi.nlm.nih.gov/pubmed/37297674
http://dx.doi.org/10.3390/healthcare11111534
work_keys_str_mv AT lopezmunizballesterosbelen trendsandoutcomesinlungtransplantationinpatientswithandwithoutidiopathicpulmonaryfibrosisinspainduringtheperiod20162020
AT lopezdeandresana trendsandoutcomesinlungtransplantationinpatientswithandwithoutidiopathicpulmonaryfibrosisinspainduringtheperiod20162020
AT jimenezgarciarodrigo trendsandoutcomesinlungtransplantationinpatientswithandwithoutidiopathicpulmonaryfibrosisinspainduringtheperiod20162020
AT zamoranoleonjosej trendsandoutcomesinlungtransplantationinpatientswithandwithoutidiopathicpulmonaryfibrosisinspainduringtheperiod20162020
AT carabantesalarcondavid trendsandoutcomesinlungtransplantationinpatientswithandwithoutidiopathicpulmonaryfibrosisinspainduringtheperiod20162020
AT cuadradocorralesnatividad trendsandoutcomesinlungtransplantationinpatientswithandwithoutidiopathicpulmonaryfibrosisinspainduringtheperiod20162020
AT delbarriojosel trendsandoutcomesinlungtransplantationinpatientswithandwithoutidiopathicpulmonaryfibrosisinspainduringtheperiod20162020
AT perezfarinosnapoleon trendsandoutcomesinlungtransplantationinpatientswithandwithoutidiopathicpulmonaryfibrosisinspainduringtheperiod20162020
AT demigueldiezjavier trendsandoutcomesinlungtransplantationinpatientswithandwithoutidiopathicpulmonaryfibrosisinspainduringtheperiod20162020